Research at UVA: The Quest to Conquer Alzheimer’s Disease

  • Dates: June 7, 2019
  • Location: Minor Hall, Room 125
  • Address: McCormick Road, Minor Hall, Charlottesville, VA 22903
  • Phone: (434) 982-4491
  • Time: 1:00 PM to 2:00 PM
  • Price: Free but RSVP Required: https://www.eventbrite.com/e/research-at-uva-the-quest-to-conquer-alzheimers-disease-tickets-60472259155
  • Website: Click to Visit Research at UVA: The Quest to Conquer Alzheimer’s Disease

Alzheimer’s disease has been the most expensive disease in the U.S. since 2013. It cost American society approximately $260 billion in 2017, a sum that will rise to more than $1 trillion by 2050 unless methods to prevent Alzheimer’s disease or significantly slow its progression can be developed soon. To that end, the Bloom lab recently obtained evidence that memantine (Namenda®), an FDA-approved drug for modest and temporary symptom relief in advanced AD patients, may also be able to prevent Alzheimer’s disease. Bloom will discuss how that discovery might lead to a clinical trial to test if daily memantine treatment beginning years before Alzheimer’s disease symptoms develop can prevent or delay symptom onset.